Learn more

INST GUSTAVE ROUSSY IGR

Overview
  • Total Patents
    25
  • GoodIP Patent Rank
    221,567
  • Filing trend
    ⇩ 100.0%
About

INST GUSTAVE ROUSSY IGR has a total of 25 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2002. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are FEMALON S P R L, PACYLEX PHARMACEUTICALS INC and TULLY TIMOTHY P.

Patent filings in countries

World map showing INST GUSTAVE ROUSSY IGRs patent filings in countries

Patent filings per year

Chart showing INST GUSTAVE ROUSSY IGRs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Raslova Hana 5
#2 Vainchenker William 5
#3 Zitvogel Laurence 5
#4 Bluteau Dominique 5
#5 Vozenin Marie Catherine 4
#6 Peronneau Pierre 4
#7 Bourhis Jean 4
#8 Deutsch Eric 4
#9 Lassau Nathalie 4
#10 Triebel Frederic 3

Latest patents

Publication Filing date Title
EP2850414A1 Characterization of biological tissues at a cellular level using red and far-red fluorescent dyes
WO2013139479A1 New diagnostic markers of specific chronic myelomonocytic leukemia (cmml)
EP2708605A1 ANKRD26 as a marker for diagnosis of thrombocytopenias
EP2492687A1 MYH10 as a new diagnostic marker of pathologies resulting from RUNX1 inactivation
EP2426216A1 Prognostic and/or predictive biomarkers and biological applications thereof
EP2371369A1 EGFR inhibitor and antiviral agent for simultaneous, separate or sequential use in the treatment and/or prevention and/or palliation of cancer
FR2850385A1 Echogenic microparticles, in particular as a contrast agent for ultrasonic exploration and / or as embols for ultrasonic detection
FR2844452A1 Modulating dendritic cell activity, e.g. for treatment of viral infections, NK-sensitive tumors or autoimmune diseases, using inhibitors or specific tyrosine kinases, e.g. c-abl, bcr/abl and c-kit